Identifying the optimal fractionation schedules for improved response rates and survival in patients with metastatic melanoma treated with ipilimumab and radiotherapy

Jason Liu, Cong Xu, Junjia Zhu, Jeffrey Sivik, Joseph J. Drabick, Heath B. Mackley

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Identifying the optimal fractionation schedules for improved response rates and survival in patients with metastatic melanoma treated with ipilimumab and radiotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences